PATENT CLAIM ANALYSIS

Application Number: 15899561
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "252030"]

Abstract:
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R 1  and R 2  are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Claim (Index 27):
The method according to  claim 26 , wherein the compound of formula (I) is chosen from:\n 6-[2-(4-Fluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one, 4-Hydroxy-6-{2-[4-(trifluoromethyl)phenyl]ethyl}pyridazin-3(2H)-one, 6-(4-Chlorobenzyl)-4-hydroxypyridazin-3(2H)-one, and a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 88.0
- Lexical Diversity: 1.18919
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14240045', '15014336', '14652484', '12739262', '10578594']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8225222958152674
- 35 USC 102 Novelty (BERT): 0.5984251756466893
- Combined Prediction Score: 0.8001125837984097
- Mean Citation Score: 406.878576
- Max Citation Score: 509.31485
- Similarity Product: 476.8109507929116

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test